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Abstract
Background: January 1, 2002, copayment for outpatient female sterilization in Norwegian public
hospitals increased from 33 euros to 750 euros after a revision of the health care system. The aim
of the present study was to investigate the effect of the new copayment system on female
sterilization epidemiology.
Methods: We retrieved data on all female sterilizations 1999–2005 (N = 23 1333) from the
Norwegian Patient Register, an administrative register to which it is mandatory for all hospitals to
report. Sterilizations with diagnostic codes indicative of vaginal delivery, caesarean section,
spontaneous abortion, ectopic pregnancy, and termination of pregnancy were analyzed separately.
All other sterilizations were defined as "interval sterilization".
Results: An abrupt fall in female sterilization was observed after the raise in copayment. Age-
adjusted incidence rates dropped from 6.3–6.8 per 1000 women in 1999–2001 to 2.2–2.3 per 1000
women during 2002–2005. Interval sterilizations dropped to 25% of the previous level after the rise
in copayment while sterilizations in conjunction with caesarean section and postpartum
sterilization remained constant.
Conclusion: For many Norwegian women seeking contraception, sterilization is no longer an
available alternative.
Background
A new copayment system for sterilization was introduced
in Norway January 1, 2002. Copayment for outpatients
increased from 33 euros to 750 euros for women and
from 27 euros to 156 euros for men. No copayment is
charged from inpatients. This substantial change in copay-
ment for sterilization was part of a revision of the health
care system [1]. Norwegian citizens have the right to free
medical care within certain limitations. In January 2002,
a system was commenced where the right to medical care
was divided into three levels, with sterilization in the low-
est priority group with corresponding high copayment
(50% and 100% of estimated costs for women and men,
respectively).
The Norwegian Patient Register is an administrative data-
base containing activity data for all public and private
hospitals in Norway [2]. Reporting is mandatory and is
linked to the re-imbursement system for funding of health
services.
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The sudden change in patient copayment together with
the complete record in the Patient Register presented us
with a unique opportunity to study the impact of the price
of the procedure on the incidence of female sterilization.
Methods
The study was approved by the Norwegian Data Inspector-
ate. Authorization for the use of sensitive health data was
obtained from the Norwegian Ministry of Health and
Social affairs.
The Norwegian Patient Register comprises more than 20
variables, including basic administrative data (institution,
dates of admission and discharge), patient data (sex, year
of birth, county of residency), and medical data. Medical
data include up to eight diagnoses coded according to the
International Classification of Diseases system, 10th Revi-
sion (ICD-10) and up to ten surgical procedures coded
according to NOMESKO's Classification of Surgical Proce-
dures (NCSP).
In Norway, sterilization can be demanded by women 25
years and older. We identified women 25–49 years old
who had undergone sterilization as indicated by diagnosis
code Z302 ("sterilization") and/or a procedure code in
the LGA group ("female sterilization").
Sterilizations with diagnostic codes indicative of vaginal
delivery (ICD-10 codes starting with O8, except O82 and
O84.2), caesarean section (codes starting with O82 and
code O84.2), spontaneous abortion (codes starting with
O0, except codes starting with O00 and O04), ectopic
pregnancy (codes starting with O00), and termination of
pregnancy (codes starting with O04) were analyzed sepa-
rately. All other sterilizations were defined as "interval
sterilization".
Sterilization procedures are also reported to Statistics Nor-
way as individual case report forms [3]. We retrieved data
from this source for comparison.
Incidence was calculated as the number of female sterili-
zations relative to the number of same-aged women per
year. Age was categorized into five-year age-groups. Age
adjusted incidence rates were calculated by using the
direct method with the female population 25–49 years
old in Norway 1999 as the reference. Population figures
were provided by Statistics Norway.
SPSS for Windows, version 13.0 (SPSS, Chicago, IL) were
used in all analyses.
Results
We identified 23315 women with a diagnostic code and/
or a procedural code indicative of sterilization over the
years 1999–2005. We excluded 131 women younger than
25 years and 51 women older than 49 years. The total
study population comprised 23133 women aged 25–49
years.
Most study participants (20931/23133, 90.5%) were
identified with both a diagnostic and a procedural code
for sterilization. Mean age at sterilization was 37.1 years
(SD 4.9), with only minor variations over the study years
(data not shown).
The number of female sterilizations was relatively stable
during 1999–2001, fell abruptly in 2002, and remained
thereafter at a constant low level (Table 1). During the
years 1999–2003 the number of female sterilizations in
Statistics Norway corresponded to 77–90% of the num-
bers in the Norwegian Patient Register. Age adjusted inci-
dence rates fell from 6.3–6.8 per 1000 women during
1999–2001 to 2.2–2.3 per 1000 in 2002–2005. During
the entire period, incidence rates for sterilization peaked
in the 35–39 year age group (Table 1). The decrease in
incidence rates over the study period was lowest among
the youngest women and strongest in the oldest age group
(53% and 73%, respectively).
The fall in sterilizations from 2001 to 2002 was confined
to interval sterilizations (Table 2). In this group, the aver-
age annual number of sterilizations during 2002–2005
was 79% lower than the average number during 1999–
2001. The number of sterilizations in conjunction with
caesarean section and postpartum sterilizations remained
stable throughout the study period (inpatients), while
Table 1: Total number of sterilizations from the Norwegian 
Patient Register and Statistics Norway1, and incidence of 
sterilization per 1000 same-aged women2




5250 5080 5483 1888 1794 1859 1779
N (Statistics 
Norway)
4727 4481 4625 1455 1580 - -
25–29 1.6 1.7 1.8 0.8 0.9 0.8 0.8
30–34 6.8 6.7 6.5 2.8 2.7 2.8 2.8
35–39 12.9 12.1 13.3 4.5 4.1 4.1 3.8
40–44 9.7 9.4 10.5 2.9 2.7 3.0 2.8
45–49 1.9 1.7 1.9 0.5 0.5 0.5 0.5
25–49 (age 
adjusted)3
6.6 6.3 6.8 2.3 2.2 2.3 2.2
1Data from one county was lacking in 2002
2Based on data from the Patient Register
3Adjusted to the age distribution of women 25–49 years old in 
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sterilizations carried out in conjunction with pregnancy
termination decreased (mainly an outpatient procedure).
Discussion
In the present study, we observed a strong decline in
female sterilizations when copayment increased from 33
euros to 750 euros January 1, 2002. The decrease was
restricted to interval sterilizations.
The major strength of present study is that we had access
to data on all female sterilizations carried out in Norway
from a single data source. The Patient Register contains
large amounts of information, including demographic
data and medical data on diagnoses and procedures.
Comparison with data from Statistics Norway showed a
lower number of female sterilizations in the latter data-
base for all years 1999–2003, indicating higher complete-
ness in reporting to the Patient Register. A detailed
comparison of sterilizations from the Patient Register and
from Statistics Norway can be found elsewhere [4].
The abrupt fall in sterilization rates which was restricted to
interval sterilization clearly coincided with the introduc-
tion of the new copayment system and we are certain that
this fall was directly linked to the increase in copayment.
Data from Statistics Norway showed a declining trend in
female sterilization during 1985–1994, a period without
changes in the copayment system [3]. This declining trend
was however gradual, and during the years most recent to
the introduction of the new copayment system (1995–
2001), the annual number of sterilizations as reported by
Statistics Norway was stable.
The situation in Norway with a strong sudden increase in
price of sterilization with a corresponding abrupt fall in
rates is to the best of our knowledge unique. Gradually
declining trends and low sterilization levels have however
been observed in other countries. Thus, it cannot be
excluded that the sterilization rates would have declined
in Norway also without changes in the copayment system.
We observed sterilization rates slightly above 6 per 1000
same-aged women before the introduction of the new
payment system and somewhat higher than 2 per 1000
thereafter. In Great Britain, sterilization rates declined
from 5 per 1000 women in 1992 to 3.5 per 1000 in 1999
[5]. During 1981 to 1995, sterilization rates fell from 15
per 1000 women to 6 per 1000 in New South Wales, Aus-
tralia [6]. A comparative study of sterilization in the Nor-
dic countries showed large country-wise variations in the
years 1980, 1988, 1990 and 1994 [7]. While rates in Den-
mark were low and relatively stable (approximately 3 per
1000 women), a declining rate was observed in Sweden
(from 6 per 1000 to 4 per 1000). In Finland female steri-
lization rates peaked at 10 per 1000 in 1990, and fell
thereafter to 8 per 1000 in 1995 [7]. National statistics
from Finland show a gradual decline in sterilization from
1996, to 5 per 1000 women in 2005 [8].
In the Nordic countries [7] and in most other countries [9]
male sterilization rates have traditionally been lower than
female rates. It could have been expected that the intro-
duction of a differential copayment for male and female
sterilization, with a considerably lower cost for men,
might have been reflected in an increase in the number
male sterilizations. However, the annual number of male
sterilizations in Norway remained stable throughout all
years 1996–2003 [3].
Norwegian inpatients are exempted from copayment. We
observed that five in six female sterilizations were interval
sterilizations before the rise in copayment. While interval
sterilizations dropped to 25% of the level in previous
years after the rise in copayment, the numbers of steriliza-
tions in conjunction with caesarean section and postpar-
tum sterilization remained constant (inpatients). Interval
sterilizations comprised approximately 60% of all sterili-
zations 2001 and onwards, comparable to figures from
the US showing that 50% of sterilizations were performed
at interval during 1994–96 [10].
Table 2: Number of female sterilizations (% of total) undertaken at interval or in conjunction with pregnancy, data from the 
Norwegian Patient Register 1999–2005
1999 2000 2001 2002 2003 2004 2005
Interval 4421 (84.2) 4253 (83.7) 4627 (84.4) 1157 (61.3) 1032 (57.5) 1115 (60.0) 1043 (58.6)
Caesarean section 415 (7.9) 416 (8.2) 459 (8.4) 501 (26.5) 524 (29.2) 532 (28.6) 534 (30.0)
Vaginal delivery 163 (3.1) 134 (2.6) 116 (2.1) 114 (6.0) 99 (5.5) 107 (5.8) 121 (6.8)
Termination of 
pregnancy
197 (3.8) 221 (4.4) 212 (3.9) 74 (3.9) 86 (4.8) 72 (3.9) 52 (2.9)
Ectopic pregnancy 34 (0.6) 34 (0.7) 41 (0.7) 29 (1.5) 39 (2.2) 24 (1.3) 18 (1.0)
Spontaneous 
abortion
20 (0.4) 22 (0.4) 28 (0.5) 13 (0.7) 14 (0.8) 9 (0.5) 11 (0.6)
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Conclusion
This population-based register study shows that after the
introduction of a 750 EUR copayment many Norwegian
women no longer consider sterilization as an available
contraception method.
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